全球伴侶動物疫苗市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計到 2034 年，伴侶動物疫苗市場規模將達到 67.3 億美元，高於 2025 年的 36.4 億美元，預計從 2026 年到 2034 年的複合年成長率將達到 7.06%。

受寵物飼養量增加和動物健康意識提升的推動，全球伴侶動物疫苗市場正經歷強勁成長。疫苗在預防犬貓等寵物感染疾病發揮著至關重要的作用，有助於延長寵物的壽命並提高其健康水平。寵物「人性化」以及寵物飼主日益成長的醫療保健投入意願，正顯著推動已開發地區和新興市場市場的擴張。

成長要素包括獸醫生物技術的進步、動物醫院就診量的增加以及寵物保險覆蓋範圍的擴大。各國政府和獸醫組織也積極推廣疫苗接種計劃，以控制通用感染疾病。此外，先進疫苗和聯合疫苗的研發也促進了市場成長，這些疫苗提高了疫苗的有效性，並減少了所需的接種次數。

隨著新疫苗研發的進展和接種方法的改進，市場預計將進一步受益。 DNA疫苗和mRNA疫苗等技術創新正吸引人們的注意。隨著寵物照護在全球家庭中日益受到重視，伴侶動物疫苗市場預計將持續強勁成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球伴侶動物疫苗市場：依疫苗類型分類

• 市場分析、洞察與預測
• 減毒活病毒疫苗
• 結合疫苗
• 去活化疫苗
• DNA疫苗
• 重組疫苗
• 其他疫苗類型

第5章 全球伴侶動物疫苗市場：依動物類型分類

• 市場分析、洞察與預測
• 狗
• 貓
• 馬
• 鳥類

第6章 全球伴侶動物疫苗市場：依給藥途徑分類

• 市場分析、洞察與預測
• 腸外
• 口服
• 鼻腔

第7章 全球伴侶動物疫苗市場：依通路分類

• 市場分析、洞察與預測
• 獸藥
• 零售藥房
• 電子商務

第8章 全球伴侶動物疫苗市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Zoetis
  • Merck Animal Health
  • Boehringer Ingelheim
  • Elanco Animal Health
  • Virbac
  • Ceva Sante Animale
  • Vetoquinol
  • HIPRA
  • Biogenesis Bago
  • Bioveta
  • Indian Immunologicals
  • Brilliant Bio Pharma
  • Durvet
  • Sinovac

The Companion Animal Vaccines Market size is expected to reach USD 6.73 Billion in 2034 from USD 3.64 Billion (2025) growing at a CAGR of 7.06% during 2026-2034.

The global companion animal vaccines market is experiencing strong growth due to increasing pet ownership and rising awareness of animal health. Vaccines play a crucial role in preventing infectious diseases in pets such as dogs and cats, ensuring longer and healthier lives. The humanization of pets and the growing willingness of owners to invest in preventive healthcare are significantly driving market expansion across both developed and emerging regions.

Key drivers include advancements in veterinary biotechnology, increasing veterinary visits, and expanding pet insurance coverage. Governments and veterinary organizations are also promoting vaccination programs to control zoonotic diseases. Additionally, the development of advanced and combination vaccines is improving efficiency and reducing the number of doses required, further supporting market growth.

Looking ahead, the market is expected to benefit from ongoing research into novel vaccines and improved delivery methods. Technological innovations such as DNA vaccines and mRNA-based solutions are gaining attention. As pet care continues to evolve into a priority for households worldwide, the companion animal vaccines market is poised for sustained and robust growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Vaccine Type

• Attenuated Live Vaccine
• Conjugate Vaccine
• Inactivated Vaccine
• Dna Vaccine
• Recombinant Vaccine
• Other Vaccine Types

By Animal Type

• Canine
• Feline
• Equine
• Avian

By Route Of Administration

• Parenteral
• Oral
• Nasal

By Distribution Channel

• Veterinary Hospital Pharmacies
• Retail Pharmacies
• E-Commerce

COMPANIES PROFILED

• Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco Animal Health, Virbac, Ceva Sant Animale, Vetoquinol, HIPRA, Biogenesis Bag, Bioveta, Indian Immunologicals, Brilliant Bio Pharma, Durvet, Sinovac
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL COMPANION ANIMAL VACCINES MARKET: BY VACCINE TYPE 2022-2034 (USD MN and Million Doses)

• 4.1. Market Analysis, Insights and Forecast Vaccine Type
• 4.2. Attenuated Live Vaccine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 4.3. Conjugate Vaccine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 4.4. Inactivated Vaccine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 4.5. Dna Vaccine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 4.6. Recombinant Vaccine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 4.7. Other Vaccine Types Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 5. GLOBAL COMPANION ANIMAL VACCINES MARKET: BY ANIMAL TYPE 2022-2034 (USD MN and Million Doses)

• 5.1. Market Analysis, Insights and Forecast Animal Type
• 5.2. Canine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 5.3. Feline Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 5.4. Equine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 5.5. Avian Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 6. GLOBAL COMPANION ANIMAL VACCINES MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN and Million Doses)

• 6.1. Market Analysis, Insights and Forecast Route Of Administration
• 6.2. Parenteral Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 6.3. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 6.4. Nasal Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 7. GLOBAL COMPANION ANIMAL VACCINES MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN and Million Doses)

• 7.1. Market Analysis, Insights and Forecast Distribution Channel
• 7.2. Veterinary Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 7.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 7.4. E-Commerce Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 8. GLOBAL COMPANION ANIMAL VACCINES MARKET: BY REGION 2022-2034 (USD MN and Million Doses)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
  • 8.2.1 By Vaccine Type
  • 8.2.2 By Animal Type
  • 8.2.3 By Route Of Administration
  • 8.2.4 By Distribution Channel
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
  • 8.3.1 By Vaccine Type
  • 8.3.2 By Animal Type
  • 8.3.3 By Route Of Administration
  • 8.3.4 By Distribution Channel
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
  • 8.4.1 By Vaccine Type
  • 8.4.2 By Animal Type
  • 8.4.3 By Route Of Administration
  • 8.4.4 By Distribution Channel
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
  • 8.5.1 By Vaccine Type
  • 8.5.2 By Animal Type
  • 8.5.3 By Route Of Administration
  • 8.5.4 By Distribution Channel
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
  • 8.6.1 By Vaccine Type
  • 8.6.2 By Animal Type
  • 8.6.3 By Route Of Administration
  • 8.6.4 By Distribution Channel
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL COMPANION ANIMAL VACCINES INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Zoetis
  • 10.2.2 Merck Animal Health
  • 10.2.3 Boehringer Ingelheim
  • 10.2.4 Elanco Animal Health
  • 10.2.5 Virbac
  • 10.2.6 Ceva Sante Animale
  • 10.2.7 Vetoquinol
  • 10.2.8 HIPRA
  • 10.2.9 Biogenesis Bago
  • 10.2.10 Bioveta
  • 10.2.11 Indian Immunologicals
  • 10.2.12 Brilliant Bio Pharma
  • 10.2.13 Durvet
  • 10.2.14 Sinovac